UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine(4-)

Term ID

CHEBI:64420

Synonyms

(2R,5S,10R,13S,16R)-16-{[(2R,3R,4R,5S,6R)-3-acetamido-2-({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}phosphinato)oxy]phosphinato}oxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}-5-[
UDP-MurNAc-tetrapeptide(4-)
UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptanedioyl-D-alanine

Definition

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: organophosphate oxoanion UDP-glycopeptide

organophosphate oxoanion UDP-glycopeptide Show first 5 Terms

Phenotype

Phenotype resulting from UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine(4-)

Phenotype where environments contain UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine(4-)

Phenotype modified by environments containing UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine(4-)

Phenotype affecting UDP-N-acetyl-alpha-D-muramoyl-L-alanyl-D-glutamyl-meso-2,6-diaminoheptanedioate-D-alanine(4-)

Human Disease Model